| NCT ID | NCT07305025 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Olavs Hospital |
| Condition | Pelvic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2025-12-16 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2025-12-16 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate if a series of up to 9 treatment sessions of electroacupuncture can be used to alleviate pain in women with suspected endometriosis, scheduled for diagnostic laparoscopy
Eligibility Criteria
Inclusion Criteria: * Women aged 18-45 years referred for diagnostic laparoscopy with suspicion of endometriosis * Experiencing moderate to severe pelvic pain * Willing to commit to the treatment schedule and follow-up * Understanding Norwegian or English to be able to communicate and fill out questionnaires Exclusion Criteria: * Pregnancy * Use of opioid pain relief * Concurrent participation in other pain management trials
Contact & Investigator
Ingrid Volløyhaug, PhD
PRINCIPAL INVESTIGATOR
St.Olavs Hopsital
Frequently Asked Questions
Who can join the NCT07305025 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Pelvic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07305025 currently recruiting?
Yes, NCT07305025 is actively recruiting participants. Contact the research team at ingrid.volloyhaug@ntnu.no for enrollment information.
Where is the NCT07305025 trial being conducted?
This trial is being conducted at Trondheim, Norway.
Who is sponsoring the NCT07305025 clinical trial?
NCT07305025 is sponsored by St. Olavs Hospital. The principal investigator is Ingrid Volløyhaug, PhD at St.Olavs Hopsital. The trial plans to enroll 38 participants.